Julia Etchin

An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element

Marc R. Mansour, Brian J. Abraham, Lars Anders et al. · Science · 2014 · 818 citations · Full text

Medicine, Genetics, Molecular Genetics +17

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou et al. · Cancer Cell · 2016 · 304 citations · Full text

Medicine, Biomedical Sciences, Drug Discovery +6

Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells

Julia Etchin, Qingxiang Sun, Alex Kentsis et al. · Leukemia · 2012 · 192 citations · Full text

Medicine, Oncology, Pharmacology +15

Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2

Eloïse Dray, Julia Etchin, Claudia Wiese et al. · Nature Structural & Molecular Biology · 2010 · 175 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +14

<scp>KPT</scp>‐330 inhibitor of <scp>CRM</scp>1 (<scp>XPO</scp>1)‐mediated nuclear export has selective anti‐leukaemic activity in preclinical models of <scp>T</scp>‐cell acute lymphoblastic leukaemia and acute myeloid leukaemia

Julia Etchin, Takaomi Sanda, Marc R. Mansour et al. · British Journal of Haematology · 2013 · 175 citations

Medicine, Oncology, Pharmacology +14